Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06217809 · ClinicalTrials.gov registry record · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
A NA study of Abstinence, Sex, sponsored by Alternatives For Girls.
- Recruiting
- Registry status
- NA
- Development phase
- 552
- Enrollment target
- 1
- Study location
NCT06217809: Recruiting NA study of Abstinence, Sex, sponsored by Alternatives For Girls.
NCT06217809 is a NA study of Abstinence, Sex that is actively recruiting participants, run by Alternatives For Girls. The registered enrollment target is 552 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06217809, a NA study of Abstinence, Sex, is actively recruiting participants, sponsored by Alternatives For Girls.
- RECRUITING
- Registry status
- NA
- Development phase
- 552 participants
- Enrollment target
- 1
- Study location
Study Summary
Alternatives For Girls (AFG's) EmpowHer curriculum is a program for youth who are 10-15 years of age. The curriculum is youth-co-led, and innovative (using online platforms and digitized presentation of material. EmpowHer addresses four adulthood preparation subjects (APS), such as parent-child communication, healthy relationships, adolescent development, and healthy life skills, and can be implemented as an after-school, in/out-of-school-time program.
Primary Outcome
Do participants in the curriculum model (EmpowHer) show reduced rates of sexual activity at 9-month follow up compared to those in a control curriculum (Sassy Science)?
Conditions Studied
Interventions
- BEHAVIORAL The intervention curriculum addresses sexual activity, abstinence, and adulthood preparation topics.
Study Locations (1)
Michigan
- Alternatives For Girls - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 552 participants |
| Start Date | 2022-02-22 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT06217809 shows while recruiting
NCT06217809 is an interventional study that assigns participants to a tested intervention. The registered 552 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Abstinence, Sex appearing as the primary indexed condition, and to 1 intervention - of which The intervention curriculum addresses sexual activity, abstinence, and adulthood preparation topics. is the first listed.
NCT06217809 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06217809 about?
NCT06217809 is a clinical study titled "EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.". Alternatives For Girls (AFG's) EmpowHer curriculum is a program for youth who are 10-15 years of age. The curriculum is youth-co-led, and innovative (using online platforms and digitized presentation of material. EmpowHer addresses four adulthood preparation subjects (APS), such as parent-child comm...
What is the current status of trial NCT06217809?
This trial is currently recruiting. It is a NA study. The enrollment target is 552 participants. The study started on 2022-02-22. Estimated completion is 2026-09-30.
What conditions does trial NCT06217809 study?
This clinical trial studies the following conditions: Abstinence, Sex.
What interventions are being tested in trial NCT06217809?
The interventions under investigation include: The intervention curriculum addresses sexual activity, abstinence, and adulthood preparation topics. (BEHAVIORAL).
Who is sponsoring clinical trial NCT06217809?
This trial is sponsored by Alternatives For Girls, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06217809 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06217809's enrollment target sits among peer trials
552 184th of 2000 higher than 1,817 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT05786924 · 554 participants · Phase 1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI